NeoTect Articles
Busy year for NCEs as major new compound classes launched
6 January 2000
NeoTect launch and P2045 data boost Diatide
8 September 1999
Diatide receives $7 million boost
16 August 1999
1st approval for Diatide's NeoTect in USA
5 August 1999
Clinical trials round-up
10 June 1999
Diatide on road to profitability with its target-and-treat strategy
11 February 1999
Diatide's NeoTect approvable says FDA - updated story
7 January 1999
Diatide's NeoTect approvable says FDA
21 December 1998
Diatide's NeoTect equivalent or superior to Miraluma
29 October 1998
Showing 1-10 of 10 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
